Gene · 3159
Papers3,810
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,810
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hsa-miR-665 Is a Promising Biomarker in Cancer Prognosis. | Cancers (Basel) | 2023 | 37894282 | PubTator, text mining | PubMed |
| Statins and Cardiomyocyte Metabolism, Friend or Foe? | J Cardiovasc Dev Dis | 2023 | 37887864 | PubTator, text mining | PubMed |
| Integrated bulk and scRNA sequence identified anoikis-related diagnostic biomarkers and potential association with immune infiltration in type A aortic dissection. | Aging (Albany NY) | 2023 | 37877967 | PubTator, text mining | PubMed |
| The landscape of SETBP1 gene expression and transcription factor activity across human tissues. | bioRxiv | 2023 | 37873221 | PubTator, text mining | PubMed |
| IGF2BP2-meidated m6A modification of CSF2 reprograms MSC to promote gastric cancer progression. | Cell Death Dis | 2023 | 37865637 | PubTator, text mining | PubMed |
| Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity. | Front Cell Dev Biol | 2023 | 37860822 | PubTator, text mining | PubMed |
| Single-cell transcriptomics provide insight into metastasis-related subsets of breast cancer. | Breast Cancer Res | 2023 | 37858183 | PubTator, text mining | PubMed |
| Overexpression of SH2D1A promotes cancer progression and is associated with immune cell infiltration in hepatocellular carcinoma via bioinformatics and in vitro study. | BMC Cancer | 2023 | 37858067 | PubTator, text mining | PubMed |
| Exploring the biosynthetic gene clusters in Brevibacterium: a comparative genomic analysis of diversity and distribution. | BMC Genomics | 2023 | 37858045 | PubTator, text mining | PubMed |
| Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways. | Drugs R D | 2023 | 37847357 | PubTator, text mining | PubMed |
| Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT. | Virchows Arch | 2023 | 37845471 | PubTator, text mining | PubMed |
| Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia. | Cancer Drug Resist | 2023 | 37842232 | PubTator, text mining | PubMed |
| Lipid metabolism as a target for cancer drug resistance: progress and prospects. | Front Pharmacol | 2023 | 37841917 | PubTator, text mining | PubMed |
| Vaccinium uliginosum and Vaccinium myrtillus-Two Species-One Used as a Functional Food. | Nutrients | 2023 | 37836403 | PubTator, text mining | PubMed |
| Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance. | Int J Mol Sci | 2023 | 37834454 | PubTator, text mining | PubMed |
| MicroRNAs and Nonalcoholic Steatohepatitis: A Review. | Int J Mol Sci | 2023 | 37833930 | PubTator, text mining | PubMed |
EGCG inhibits the inflammation and senescence inducing properties of MDA-MB-231 triple-negative breast cancer (TNBC) cells-derived extracellular vesicles in human adipose-derived mesenchymal stem cells. | Cancer Cell Int | 2023 | 37833751 | PubTator, text mining | PubMed |
| Dual mechanism of Let-7i in tumor progression. | Front Oncol | 2023 | 37829341 | PubTator, text mining | PubMed |
| Divergent molecular events underlying initial T-cell commitment in human prenatal and postnatal thymus. | Front Immunol | 2023 | 37828991 | PubTator, text mining | PubMed |
| Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine. | Endocrinol Metab (Seoul) | 2023 | 37828709 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3159/papers?page=16